A systematic survey of the response of a model NF-κB signalling pathway to TNFα stimulation
暂无分享,去创建一个
David S. Broomhead | Douglas B. Kell | Pawel Paszek | Mark R. Muldoon | Caroline A. Horton | D. Broomhead | D. Kell | C. Horton | M. White | H. Yue | P. Paszek | Yunjiao Wang | Yunjiao Wang | Hong Yue | Michael R.H. White | M. Muldoon
[1] S. Paul,et al. Cutting Edge: TCR Ligation Triggers Digital Activation of NF-κB , 2010, The Journal of Immunology.
[2] David A. Rand,et al. Physiological levels of TNFα stimulation induce stochastic dynamics of NF-κB responses in single living cells , 2010, Journal of Cell Science.
[3] Timothy K Lee,et al. Single-cell NF-κB dynamics reveal digital activation and analogue information processing , 2010, Nature.
[4] N. Gillespie,et al. Unravelling the complexities of trust and culture , 2010 .
[5] V. Speirs,et al. Expression of COX-2, NF-κB-p65, NF-κB-p50 and IKKα in malignant and adjacent normal human colorectal tissue , 2009, British Journal of Cancer.
[6] D. S. Broomhead,et al. Pulsatile Stimulation Determines Timing and Specificity of NF-κB-Dependent Transcription , 2009, Science.
[7] Fei He,et al. Sensitivity analysis and robust experimental design of a signal transduction pathway system , 2008 .
[8] S. Ghosh,et al. Shared Principles in NF-κB Signaling , 2008, Cell.
[9] Marek Kimmel,et al. Single TNFα trimers mediating NF-κB activation: stochastic robustness of NF-κB signaling , 2007, BMC Bioinformatics.
[10] Sandeep Krishna,et al. PULSES AND CHAOS: DYNAMICAL RESPONSE IN A SIMPLE GENETIC OSCILLATOR , 2007 .
[11] L. Staudt,et al. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. , 2007, Cancer cell.
[12] Frank Schilder. Rauto: running AUTO more efficiently , 2007 .
[13] D. Kell,et al. Sensitivity analysis of an oscillatory signal transduction pathway , 2007 .
[14] Bharat B. Aggarwal,et al. Nuclear factor‐κB (nf‐κB) is frequently expressed in lung cancer and preneoplastic lesions , 2006 .
[15] Hong Wang,et al. Insights into the behaviour of systems biology models from dynamic sensitivity and identifiability analysis: a case study of an NF-kappaB signalling pathway. , 2006, Molecular bioSystems.
[16] S. Gerondakis,et al. Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models , 2006, Oncogene.
[17] A. Baldwin,et al. Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression , 2006, Oncogene.
[18] C Gélinas,et al. Current insights into the regulation of programmed cell death by NF-κB , 2006, Oncogene.
[19] S. Ghosh,et al. NF-κB and the immune response , 2006, Oncogene.
[20] Marek Kimmel,et al. Stochastic regulation in early immune response. , 2006, Biophysical journal.
[21] A. Hoffmann,et al. Circuitry of nuclear factor kappaB signaling. , 2006, Immunological reviews.
[22] Kim Sneppen,et al. Minimal model of spiky oscillations in NF-kappaB signaling. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[23] K. Matalka,et al. Measurement of protein cytokines in tissue extracts by enzyme-linked immunosorbent assays: application to lipopolysaccharide-induced differential milieu of cytokines. , 2005, Neuro endocrinology letters.
[24] James R. Johnson,et al. Oscillations in NF-κB Signaling Control the Dynamics of Gene Expression , 2004, Science.
[25] V. Sée,et al. Calcium-dependent regulation of the cell cycle via a novel MAPK–NF-κB pathway in Swiss 3T3 cells , 2004, The Journal of cell biology.
[26] Somasekar Seshagiri,et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling , 2004, Nature.
[27] David S. Broomhead,et al. Sensitivity analysis of parameters controlling oscillatory signalling in the NF-/sub K/Bpathway: the roles of IKK and I/sub K/B/sub alpha/ , 2004 .
[28] Marek Kimmel,et al. Mathematical model of NF- κB regulatory module , 2004 .
[29] D. Broomhead,et al. Sensitivity analysis of parameters controlling oscillatory signalling in the NFk B pathway : the roles of IKK and I k B a , 2004 .
[30] Sulochana D. Das,et al. Role of TNF-α in host immune response in tuberculous pleuritis , 2003 .
[31] A. Hoffmann,et al. The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .
[32] Michael Karin,et al. NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.
[33] David G Spiller,et al. Multi-parameter analysis of the kinetics of NF-kappaB signalling and transcription in single living cells. , 2002, Journal of cell science.
[34] Bard Ermentrout,et al. Simulating, analyzing, and animating dynamical systems - a guide to XPPAUT for researchers and students , 2002, Software, environments, tools.
[35] H. Pahl. Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.
[36] A. Taniguchi,et al. Plasma concentrations of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in patients with anorexia nervosa. , 1999, The Journal of clinical endocrinology and metabolism.
[37] H. Pahl,et al. Activators and target genes of Rel/NF-kappaB transcription factors. , 1999, Oncogene.
[38] Ebrahim Zandi,et al. Direct Phosphorylation of IκB by IKKα and IKKβ: Discrimination Between Free and NF-κB-Bound Substrate , 1998 .
[39] M J May,et al. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.
[40] D. Goeddel,et al. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[41] D. Thomas,et al. Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B , 1995, Molecular and cellular biology.
[42] G P Nolan,et al. The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms. , 1993, Genes & development.
[43] M. Lamy,et al. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. , 1989, Critical care medicine.